http://www.easyir.com/easyir/prssrel.do?easyirid=C39BA6F35995150B&version=live&prid=530067
Based on APPY press release, the FDA approval is expected this quarter.
Considering their 52 week high at $7.78, this stock still has potential of going higher in case of FDA approval. APPY has moved almost 70% since last month.
No comments:
Post a Comment